Induction of invasive phenotype by Casodex in hormone-sensitive prostate cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 83, Issue 1-5, 2002, Pages 101-111

  Zhan, Ping ^a   Lee, Edmund Chun Yu ^a   Packman, Kathryn ^a   Tenniswood, Martin ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Casodex; LNCaP; Metastasis; Prostate cancer; Tumor invasion

Indexed keywords

BICALUTAMIDE; DNA FRAGMENT; INTERSTITIAL COLLAGENASE; PROTEIN P60; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANILIDE; ANTINEOPLASTIC AGENT;

CANCER CELL CULTURE; CANCER INVASION; CELL DEATH; CELL VIABILITY; CONFERENCE PAPER; HORMONE SENSITIVITY; HUMAN; IN VITRO STUDY; PHENOTYPE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; TUMOR REGRESSION; ZYMOGRAPHY; ARTICLE; CELL CULTURE; CELL CYCLE; CULTURE MEDIUM; DRUG EFFECT; FLOW CYTOMETRY; KINETICS; MALE; METABOLISM; METASTASIS; PATHOLOGY; PROSTATE TUMOR; TIME;

ANILIDES; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL DEATH; CULTURE MEDIA, SERUM-FREE; DNA FRAGMENTATION; FLOW CYTOMETRY; HUMANS; KINETICS; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHENOTYPE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037783494     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00275-3     Document Type: Conference Paper

References (25)

1. Guenette R.S., Daehlin L., Mooibroek M., Wong K., Tenniswood M.P. Thanatogen expression during involution of the rat ventral prostate after castration. J. Androl. 15:1994;200-211.
2. Zakeri Z., Bursch W., Tenniswood M., Lockshin R.A. Cell death: programmed necrosis, or other? Cell Death Differ. 2:1995;83-92.
3. Lee C. Physiology of castration-induced regression of the rat prostate. Proc. Clin. Biol. Res. 75A:1981;145-159.
4. Lee C., Sensibar J.A. Proteins of the rat prostate. II. Synthesis of new proteins in the ventral lobe during castration-induced regression. J. Urol. 138:1987;903-908.
5. Bursch W., Kleine L., Tenniswood M.P. The biochemistry of cell death by apoptosis. Biochem. Cell. Biol. 68:1990;1071-1074.
6. Chinnaiyan A.M., Dixit V. Portrait of an executioner: the molecular mechanism of Fas/Apo 1-induced apoptosis. Semin. Immunol. 9:1997;69-76.
7. Kroemer G., Dallaporta B., Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Ann. Rev. Physiol. 60:1998;619-642.
8. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
9. Colombel M., Symmans F., Gil S., O'Toole K.M., Chopin D., Benson M., Olsson C.A., Korsmeyer S., Buttyan R. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol. 143:1993;390-400.
10. Muntzing J. Androgen and collagen as growth regulators of the rat ventral prostate. Prostate. 1:1980;71-78.
11. Sensibar J.A., Liu X.X., Patai B., Alger B., Lee C. Characterization of castration-induced cell death in the rat prostate by immunohistochemical localization of cathepsin D. Prostate. 16:1990;263-276.
12. Freeman S.N., Rennie P.S., Chao J., Lund L.R., Andreasen P.A. Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats. Biochem. J. 269:1990;189-193.
13. Guenette R.S., Mooibroek M., Wong P., Tenniswood M. Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands. Eur. J. Biochem. 226:1994;311-321.
14. Wilson M.J., Ditmanson J.V., Sinha A.A., Estensen R.D. Plasminogen activator activities in the ventral and dorsolateral prostatic lobes of aging Fischer 344 rats. Prostate. 16:1994;147-161.
15. Nicholson D., Ali A., Thornberry N., Vaillancourt J., Ding C., Gallant M., Gareau Y., Griffin P., Labelle M., Lazebnik Y., Munday N., Raju S., Smulson M., Yamin T.T., Lu V., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
16. Hacker G., Hawkins C.J., Smith K.G., Vaux D.L. Effects of viral inhibitors of apoptosis in models of mammalian cell death. Behring Inst. Mitt. 7:1996;118-126.
17. Arends M.J., Morris R.G., Wyllie A.H. Apoptosis. The role of the endonuclease. Am. J. Pathol. 136:1990;593-608.
18. 2+ and pH. Biochem. Biophys. Res. Commun. 186:1992;782-789.
19. Walker P.R., Sikorska M. Endonuclease activities, chromatin structure and DNA degradation in apoptosis. Biochem. Cell Biol. 72:1994;615-623.
20. C.D. Bortner, J.A. Cidlowski, Cell volume regulation and the movement of ions during apoptosis, in: J.L. Tilly, J.F. Straus, M. Tenniswood (Eds.), Serono Symposium on Cell Death in Reproductive Physiology, Springer, New York, 1996, pp. 230-248.
21. Hedlund T., Miller G.J. A serum-free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines. Prostate. 24:1994;221-228.
22. Liotta L., Stetler-Stevenson W.G. Metalloproteinases and cancer invasion. Semin. Cancer Biol. 1:1990;107-115.
23. Sloane B.F. Cathepsin B and cystatins: evidence for a role in cancer progression. Semin. Cancer Biol. 1:1990;137-152.
24. Jung K., Lein M., Ulbrich N., Rudolph B., Henke W., Schnorr D., Loening S.A. Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: analytical aspects. Prostate. 34:1998;130-136.
25. Hoosein N.M., Boyd D.D., Hollas W.J., Mazar A., Henkin J., Chung L.W.K. Involvement of urokinase and its receptor in the invasiveness of human prostate carcinoma cell lines. Cancer Commun. 3:1991;255-264.